Tilray Brands (TLRY) Cash & Equivalents (QoQ) (2018 - 2026)
Tilray Brands (TLRY) Cash & Equivalents (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 12.08% |
| Feb 28, 2026 | -17.06% |
| Nov 30, 2025 | -6.84% |
| Aug 31, 2025 | 19.47% |
| Nov 30, 2024 | -7.55% |
| Aug 31, 2024 | -10.14% |
| May 31, 2024 | 56.13% |
| Feb 29, 2024 | 2.01% |
| Nov 30, 2023 | -19.24% |
| Aug 31, 2023 | -14.09% |
| May 31, 2023 | 25.23% |
| Feb 28, 2023 | -13.26% |
| Nov 30, 2022 | -61.23% |
| Aug 31, 2022 | 17.97% |
| May 31, 2022 | 48.96% |
| Feb 28, 2022 | -15.84% |
| Nov 30, 2021 | -11.83% |
| Aug 31, 2021 | -22.96% |
| Mar 31, 2020 | 79.76% |
| Dec 31, 2019 | -3.36% |